A detailed history of Iconiq Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Iconiq Capital, LLC holds 3,457 shares of LLY stock, worth $2.96 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,457
Previous 1,785 93.67%
Holding current value
$2.96 Million
Previous $1.58 Million 68.75%
% of portfolio
0.06%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $1.22 Million - $1.56 Million
1,672 Added 93.67%
3,457 $2.67 Million
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $997,604 - $1.24 Million
1,292 Added 262.07%
1,785 $1.58 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $357,360 - $448,156
493 New
493 $446,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $814B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Iconiq Capital, LLC Portfolio

Follow Iconiq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iconiq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iconiq Capital, LLC with notifications on news.